Clinical
RSSArticles
New RNA Interference-Based Therapy for Hypertension
A randomized, double-blind, placebo-controlled trial of a range of doses of a new ribonucleic acid (RNA) interference drug that reduces hepatic angiotensinogen levels has shown significant mean 24-hour systolic blood pressure reductions at three months after a single subcutaneous injection.
Research Confirms the Value of Title X for Improving Contraception Access
Clients of Title X programs have greater access to a wide range of contraceptive methods, although reach has been limited by federal funding, state laws, and the Trump-era gag rule. A study revealed that people receiving contraception care from non-Title X clinics had lower proportions of receiving long-acting reversible contraception methods, nonoral hormonal methods, and extended supplies of oral contraceptives.
State Laws and Court Decisions Bring More Uncertainty to Reproductive Health
In recent months, abortion-ban states have seen even more drastic bills and changes to their citizens’ reproductive health and lives. While abortion bans have closed clinics and prevented physicians from providing standard care to women experiencing pregnancy crises, the states have gone even further, now threatening contraceptives and fertility treatment.
New Research on Advance Provision Reveals Interest and Use in United States Since 2022
Interest in advance provision of abortion medication was high even before the U.S. Supreme Court overturned Roe v. Wade, according to recent research. Many of those interested in advance provision were more likely to be highly motivated to prevent pregnancy. They had been using highly effective contraceptives, were well-educated, had private insurance, and were not poor.
As Uncertainty Looms, More People Request Advance Provision of Mifepristone
Interest in advance provision of abortion medications mifepristone and misoprostol has increased dramatically in the post-Roe era. It remains popular as a U.S. Supreme Court case looms over whether mifepristone should remain available. Advance provision is one tool to help expand access to the medication.
Gestational Diabetes Mellitus: An Update on Care
Early detection of gestational diabetes mellitus (GDM) allows for the implementation of appropriate interventions to reduce the adverse effects of uncontrolled hyperglycemia, making GDM screening an integral part of prenatal care. However, the question of whether to adopt universal or selective (risk-based) screening for GDM has been a subject of ongoing debate and lacks a clear international consensus.
Is Cannabis Abuse During Pregnancy Associated with Poor Neonatal Outcomes?
Cannabis use disorder is associated with small but significant increased risks measured in multiple neonatal outcomes.
Permanent Contraception Regret in the Modern Age
In this Canadian cross-sectional survey of a convenience sample of 844 patients who had undergone female sterilization, the prevalence of regret was 16%.
Pelvic Exams During Annual Gynecologic Visits
A retrospective chart review of 1,121 patients undergoing annual gynecology exams showed that 1.2% (95% confidence interval [CI], 0.5 to 1.9) of asymptomatic patients had physical exam findings on pelvic exam compared to 32.4% (95% CI, 27.0 to 37.8) of symptomatic patients.
Bigeminy and What Else?
The medical providers in this case were concerned the cause of the bigeminal rhythm in the figure below was sinoatrial block. Do you agree? Are there other things to be concerned about?